Clinical Trial Update: Glutaminergic Transmission in Autism : Molecular Imaging Exploration [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating glutamatergic transmission in autism and Fragile X syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Fragile Syndrome

Snippet

Sponsor: University Hospital, Tours | Conditions: Autism, Fragile-X Syndrome (FXS) | Phase 1 | Status: COMPLETED